Loading clinical trials...
Loading clinical trials...
A Low-Interventional Study Of AAV9 Neutralizing Antibody Seroconversion in Household Contacts of Participants Within the C3391003 Clinical Trial
Conditions
Interventions
Blood Draw
Locations
1
United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Start Date
August 17, 2022
Primary Completion Date
February 27, 2024
Completion Date
February 27, 2024
Last Updated
February 26, 2025
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions